Q-1037 , 45th Parliament, 1st session May 26, 2025, to present

With regard to the response to Order Paper Question Q-763 and Health Canada, the Public Health Agency of Canada and the National Advisory Committee on Immunization, Canadian Institutes of Health Research, the National Research Council, and the costs and expenses associated with COVID-19 vaccine benefits and risks since January 2020: (a) how much money was spent investigating and researching the benefits of the COVID-19 vaccine, broken down by (i) month, (ii) expense or project name, (iii) start and end date, (iv) total cost, (v) description; (b) how much money was spent investigating and researching the risks and adverse effects of the COVID-19 vaccine, broken down by (i) month, (ii) expense or project name, (iii) start and end date, (iv) total cost, (v) description; (c) how much money was spent informing Canadians of the benefits of the COVID-19 vaccine, broken down by (i) expense name, (ii) date, (iii) cost, (iv) overview of expense; (d) how much money was spent informing Canadians about the risks and adverse effects of the COVID-19 vaccine, broken down by (i) expense name, (ii) date, (iii) cost, and (iv) overview of expense; (e) how much money was spent promoting the COVID-19 vaccines, including grants, working groups, research projects, contractors, advertising, influencers, surveys, publications and behavioural assessments, broken down by (i) type of promotion, (ii) expense, (iii) date, (iv) total cost, (v) description; (f) how much money was spent informing health professionals of the risks and adverse effects of the COVID-19 vaccine, broken down by (i) expense, (ii) date, (iii) total cost, (iv) description; (g) how much money was spent informing Government of Canada employees, contractors, or federally regulated companies on the benefits of the COVID-19 vaccine, broken down by (i) expense, (ii) date, (iii) description; and (h) how much money was spent informing Government of Canada employees, contractors or federally regulated companies on the risks and adverse effects of the COVID-19 vaccine, broken down by (i) expense, (ii) date, (iii) description?